8-KEarnings & ResultsExhibits & Filings

GILEAD SCIENCES, INC. 8-K Report, Financial Results (Feb 1, 2022)

Filed February 1, 2022For Securities:GILD

Summary

Gilead Sciences, Inc. (GILD) filed an 8-K on February 1, 2022, to report its financial results for the quarter and year ended December 31, 2021. The filing primarily directs investors to a press release (Exhibit 99.1) containing detailed financial information, including both GAAP and non-GAAP measures. Management emphasizes the utility of non-GAAP figures for internal operational planning and budgeting, and suggests investors review these alongside the official GAAP statements. A reconciliation between GAAP and non-GAAP figures is provided within the press release. Investors should note that the information furnished in this 8-K, including the press release, is not deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934 and therefore does not carry the same liabilities. This filing serves as a notification of the release of earnings data, with the comprehensive details available in the accompanying press release. Key performance indicators and strategic updates are expected to be found within that document.

Key Highlights

  • 1Gilead Sciences announced its financial results for the fourth quarter and full year ended December 31, 2021, via an 8-K filing on February 1, 2022.
  • 2The filing incorporates a press release (Exhibit 99.1) detailing the company's financial performance.
  • 3Both GAAP (Generally Accepted Accounting Principles) and non-GAAP financial measures are presented in the press release.
  • 4Management believes non-GAAP financial information is useful for investors, as it is used internally for operational and financial planning.
  • 5A reconciliation between GAAP and non-GAAP financial figures is provided within the press release.
  • 6The information furnished in the 8-K and press release is not considered "filed" under Section 18 of the Exchange Act.
  • 7The Cover Page Interactive Data File is included as Exhibit 104.

Frequently Asked Questions

The detailed financial results are available in the press release filed as Exhibit 99.1 to the 8-K filing made on February 1, 2022. This press release contains both GAAP and non-GAAP financial information, along with a reconciliation between the two.

Gilead Sciences presents non-GAAP financial measures because management uses this information internally for operating, budgeting, and financial planning. They believe it can be useful for investors when considered alongside the official GAAP financial statements, providing an alternative view of operational performance. However, investors should be aware that non-GAAP measures may be defined and calculated differently by other companies.

No, the information included in this 8-K filing, specifically the press release (Exhibit 99.1) and the information in Item 2.02 and Item 9.01, is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. Therefore, it is not subject to the liabilities under that section.